ReviewCurrent urology reports2026
Single Port Robotic Surgery in Benign Urologic Disease - A Review of Contemporary Applications and Outcomes.
Review in Current urology reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purpose of reviewThe advent of the Intuitive da Vinci single-port (SP) robotic system represents a pivotal evolution in minimally invasive urologic surgery, offering enhanced dexterity, improved surgical ergonomics, and reduced patient morbidity. This review is designed to provide a comprehensive evaluation of current literature regarding the feasibility, efficacy, cost considerations, and clinical applications of the SP platform across various benign urologic surgeries including pyeloplasty, ureteral reconstruction, donor nephrectomy, renal auto-transplantation, partial cystectomy, and simple prostatectomy. The review also analyzes current limitations of the robotic platform including a narrower range of available instruments, diminished instrument grip strength, and a steeper learning curve. RECENT
findingsAcross these procedures, the SP system demonstrates comparable operative outcomes when compared to multi-port (MP) and open approaches. The SP system also has notable advantages in postoperative analgesia, incisional cosmesis, and hospital length of stay. The system's low-profile design and ability to maintain an extraperitoneal approach confer distinct benefits in patients with complex surgical histories or hostile abdomens. Although the SP platform incurs higher disposable instrument costs, overall expenditures are mitigated with decreased hospital length of stay and reduced postoperative care requirements. As surgical experience and technological refinements progress, the SP robotic platform is anticipated to achieve broader integration in benign urology. Overall, SP robotic surgery offers a safe, effective, and patient-centered alternative to established minimally invasive techniques with the potential to further optimize perioperative outcomes and redefine the standard of care in contemporary urologic practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.